Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
土曜日, 9 05

Encompass Health Corp

EHCNYSE
Trade with Public
Trade with Public
$121.79
-0.80-0.65%
近くで: Sep 4, 5:00 PM EST
$121.79
N/A
時間外: Sep 4, 4:00 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

Encompass Health Financials

Encompass Health (EHC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.375B-$6.470B to $6.410B-$6.490B vs $6.421B Est

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.375 billion-$6.470 billion to $6.410 billion-$6.490 billion vs
Benzinga Newsdesk

PRO
Encompass Health Q2 Adj. EPS $1.55 Beats $1.48 Estimate, Sales $1.597B Beat $1.571B Estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.48 by 4.73 percent. This is a 10.71 percent increase over earnings of $1.40 per share from the
Benzinga Newsdesk

PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.365B-$6.465B to $6.375B-$6.470B vs $6.423B Est

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.365 billion-$6.465 billion to $6.375 billion-$6.470 billion vs
Benzinga Newsdesk

PRO
Encompass Health Q1 Adj. EPS $1.60 Beats $1.50 Estimate, Sales $1.586B Beat $1.569B Estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.60 per share which beat the analyst consensus estimate of $1.50 by 6.67 percent. This is a 16.79 percent increase over earnings of $1.37 per share from the
Benzinga Newsdesk

Earnings Scheduled For April 30, 2026

Benzinga Insights

PRO
Encompass Health Sees FY2026 Adj EPS $5.81-$6.10 vs $5.81 Est; Sees Sales $6.365B-$6.465B vs $6.453B Est

Encompass Health (NYSE:EHC) is looking for FY2026 Adj EPS of $5.81-$6.10 vs $5.81 analyst estimate. sees sales of $6.365 billion-$6.465 billion vs $6.453 billion analyst estimate.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved